Latest News

09:58 AM AMA and United Healthcare Combine Efforts to Once Again To Push CMS To Institute Algorithmic and ICD Coding To Rip Off Patients/Deny Access–It’s the Next Chapter of Excess Scoring in the US To Keeps Inequality/Segmentation Rolling
7:12 PM Algorithms Rule Us All--Automated Risk Scores…Tons of Error Bars, Bias and More-The US Digital Consumer Scoring System For Corporate Profit Keeps Raging On…VPRO documentary–2018
09:13 AM Pharmacy Benefit Managers Are Not Much More Than “Complex Well-Greased Algorithmic Human Scoring Machines” That Deny or Allow Access To Drugs To Create/Substantiate Big Corporate Profits
7:45 PM Optum/United Healthcare Quietly Sold Optum Hospice to Compassus in December of 2016-And Compassus Is Now Contracted Under Optum Services to Manage the Facilities, Services and Provide the OptumCare Doctors
12:49 PM Algorithms, Scoring Metrics, Privacy and more in today’s Healthcare business world–The Healthcare Algo Cartel
9:54 PM Pharmacy Benefit Managers Invade Medical Records and Electronically Connect Cash Patients to RX Discount Cards-OptimizeRX-to SingleCare to OptumRX
08:59 AM “One Trick Algo World” Needs to be Licensed and Indexed–Spurious Correlations “For Profit” Are Out of Control
8:11 PM DOJ Enters WhistleBlower Law Suit Against United Healthcare–Risk Fiddling for Profit, A Walk Back Down Ingenix Memory Lane Again

Home » Medically Related » Pharma/FDA News » Mallinckrodt Buys Cadence Pharma for $1.3 Billion

Mallinckrodt Buys Cadence Pharma for $1.3 Billion

Both companies are in the pain business and this gives Mallinckrodt Cadence's pain drug Ofirmev which is an injectable version of acetaminophen. In addition to opioid pain relievers Mallinckrodt also carries quite a few central nervous system products.

Years ago in logistics I used to do business with Mallinckrodt in Irvine. BD

An Irish pharmaceutical company agreed to acquire Cadence Pharmaceuticals Inc. in San Diego for about $1.3 billion in an effort to boost its specialty drugs portfolio.

Dublin-based Mallinckrodt agreed to pay $14 a share for the company, a 26% premium over Cadence's closing price Monday of $11.07. The boards of both companies have approved the deal.

http://www.latimes.com/business/la-fi-mallinckrodt-cadence-20140212,0,6595114.story#ixzz2t5jd1KE6

Related Posts

Pharmacy Benefit Managers Are Not Much More Than “Complex Well-Greased Algorithmic Human Scoring Machines” That Deny or Allow Access To Drugs To Create/Substantiate Big Corporate Profits
So let’s get down to what’s really happening here. Once upon a time the PBM models were a diff[...]
Optum/United Healthcare Quietly Sold Optum Hospice to Compassus in December of 2016-And Compassus Is Now Contracted Under Optum Services to Manage the Facilities, Services and Provide the OptumCare Doctors
Optum certainly kept this very quiet when they sold their hospice facilities to Compassus and I don’[...]
Algorithms, Scoring Metrics, Privacy and more in today’s Healthcare business world–The Healthcare Algo Cartel
This is a video of a recent presentation I did at the 74th Annual AAPS (American Association of Phys[...]
Pharmacy Benefit Managers Invade Medical Records and Electronically Connect Cash Patients to RX Discount Cards-OptimizeRX-to SingleCare to OptumRX
This should not really come as a big surprise as what hasn’t the pharmacy benefit managment business[...]
“One Trick Algo World” Needs to be Licensed and Indexed–Spurious Correlations “For Profit” Are Out of Control
With prediction tools and apps being all the rage today, their reliability and accuracy are not alwa[...]

0 comments :

Post a Comment

:))

;((

:-)

=))

;-(

:-d

@-)

:>)

(o)

[-(

:-?

(p)

:-s

(m)

8-)

:-t

:-b

b-(

:-#

=p~

$-)

(b)

(f)

x-)

(k)

(h)

(c)

cheer

Click to see the code!
To insert emoticon you must added at least one space before the code.

Subscribe to: Post Comments ( Atom )

counter for blogger

Google Analytics Alternative